Massive new study aims to unlock secrets of chronic inflammation

NCT ID NCT04334031

First seen May 06, 2026 · Last updated Jun 12, 2026 · Updated 10 times

Summary

This study is creating a large database and biobank from 2200 patients with chronic inflammatory diseases like lupus, multiple sclerosis, and severe asthma. Researchers will track patients over time to identify new markers that can predict disease activity, treatment response, and side effects. The goal is to improve future treatments and quality of life for people living with these conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hop Claude Huriez Chu Lille

    RECRUITING

    Lille, 59037, France

    Contact Phone: •••-•••-••••

Conditions

The condition(s) this trial relates to.

angioedema asthma atopic eczema Behcet disease multiple sclerosis psoriatic arthritis systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.